Related Experiment Video
Updated: Dec 8, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Development of an Algorithm for Determining of Genetic Risk at the Primary Healthcare Level - A New Tool for Primary
Polona Selič1, Zalika Klemenc-Ketiš1,2,3, Erika Zelko2,3
1University of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nasip 58, 1000 Ljubljana, Slovenia.
Insights
A new algorithm will assess genetic disease risk using family history data in Slovenia. This tool aims to identify individuals at higher risk for monogenic and polygenic diseases, improving preventive care.
Area of Science:
- Genetics
- Preventive Medicine
- Public Health
Background:
- Family history (FH) is crucial for preventive care but limited to 1-2 generations and specific diseases.
- Current FH inquiries in Slovenia often exclude diseases with probable genetic causes.
- No application-based algorithms exist in Slovenia for assessing chronic disease risk based on FH.
Purpose of the Study:
- To develop a web application-based algorithm for determining risk levels of monogenic and polygenic diseases.
- To enhance risk assessment beyond traditional family history by incorporating a broader range of genetic factors.
- To provide a public health tool for identifying individuals at increased risk of genetic diseases.
Main Methods:
- Developing a web application algorithm for risk assessment.
- Collecting data from approximately 1,000 healthy individuals attending preventive examinations at 40 model family medicine practices (MFMP).
- Gathering demographic data, three-generational FH, medical history of risk factors, and other clinical data.
Main Results:
- The algorithm's results will be validated using clinical genetic approaches, including family pedigrees and next-generation sequencing.
- Risk assessment for genetic diseases in the Slovenian population will be determined.
- Clinical pathways will be developed based on the assessed risk levels.
Conclusions:
- The study expects to contribute to the effective identification of individuals at increased risk for selected genetic diseases.
- The public health tool will aid in assessing family predisposition to genetic conditions.
- This initiative aims to reduce the public health burden associated with genetic diseases.
Introduction:
Family history (FH) is an important part of the patients' medical history during preventive management at model family medicine practices (MFMP). It currently includes a one (or two) generational inquiry, predominately in terms of cardiovascular diseases, arterial hypertension, and diabetes, but not of other diseases with a probable genetic aetiology. Beside family history, no application-based algorithm is available to determine the risk level for specific chronic diseases in Slovenia.
Methods:
A web application-based algorithm aimed at determining the risk level for selected monogenic and polygenic diseases will be developed. The data will be collected in MFMP; approximately 40 overall with a sample including healthy preventive examination attendees (approximately 1,000). Demographic data, a three-generational FH, a medical history of acquired and congenital risk factors for the selected diseases, and other important clinical factors will be documented.
Results:
The results will be validated by a clinical genetic approach based on family pedigrees and the next-generation genetic sequencing method. After the risk of genetic diseases in the Slovenian population has been determined, clinical pathways for acting according to the assessed risk level will be prepared.
Conclusion:
By means of a public health tool providing an assessment of family predisposition, a contribution to the effective identification of people at increased risk of the selected monogenic and polygenic diseases is expected, lessening a significant public health burden.
Related Concept Videos
Preventive Healthcare Services
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

